Combined detection of PAX1 methylation and p16/Ki-67 dual staining improves diagnostic performance for atypical squamous cells in cervical cancer

Combined detection of PAX1 methylation and p16/Ki-67 dual staining improves diagnostic performance for atypical squamous cells in cervical cancer

Objective To compare paired boxed gene 1(PAX1) methylation and p16/Ki-67 double staining alone and in combination in thinprep cytologic test (TCT) for distinguishing atypical squamous cells of undetermined significance (ASC-US) and low-grade squamous intraepithelial lesion (LSIL) population. Methods...

Full description

Bibliographic Details
Main Authors:	WANG Yuanpei, LIU Yuchen, WEN Jing
Format:	Article
Language:	zho
Published:	Editorial Office of Journal of Army Medical University 2024-02-01
Series:	陆军军医大学学报
Subjects:	methylation of pax1 p16/ki-67 double staining cervical cancer thinprep cytologic test
Online Access:	http://aammt.tmmu.edu.cn/html/202302133.htm

Similar Items

Interobserver variability and accuracy of p16/Ki-67 dual immunocytochemical staining on conventional cervical smears
by: Veronika Kloboves Prevodnik, et al.
Published: (2019-05-01)

Correlation between P16/Ki67 in cervical cytology and diagnosis of cervical intraepithelial neoplasia 2–3 in Thai women infected with high-risk types of human papillomavirus
by: Manasawee Srisuttayasathien, et al.
Published: (2024-03-01)

Enhancing Cervical Cancer Screening: Review of p16/Ki-67 Dual Staining as a Promising Triage Strategy
by: Yung-Taek Ouh, et al.
Published: (2024-02-01)

Triaging HPV-Positive Cervical Samples with p16 and Ki-67 Dual Stained Cytology within an Organized Screening Program—A Prospective Observational Study from Western Norway
by: Irene Tveiterås Øvestad, et al.
Published: (2023-04-01)

Liquid-Based Screening Tests Results: HPV, Liquid-Based Cytology, and P16/Ki67 Dual-Staining in Private-Based Opportunistic Cervical Cancer Screening
by: Martyna Trzeszcz, et al.
Published: (2021-08-01)

Significance of Triple Detection of p16/ki-67 Dual-Staining, Liquid-Based Cytology and HR HPV Testing in Screening of Cervical Cancer: A Retrospective Study
by: Li Yu, et al.
Published: (2022-06-01)

Evaluation of the training program for p16/ Ki-67 dual immunocytochemical staining interpretation for laboratory staff without experience in cervical cytology and immunocytochemistry
by: Prevodnik Veronika Kloboves, et al.
Published: (2020-03-01)

Role of p16/Ki-67 Dual immunostaining in detection of cervical cancer precursors
by: Diya Das, et al.
Published: (2018-01-01)

HPV genotyping and p16/Ki-67 test significantly improve detection rate of high-grade cervical squamous intraepithelial lesion
by: Piotr Lewitowicz, et al.
Published: (2019-12-01)

p16/Ki-67 dual staining has a better accuracy than human papillomavirus (HPV) testing in women with abnormal cytology under 30 years old
by: Laurențiu Pirtea, et al.
Published: (2019-11-01)

Performance of p16/Ki67 Immunostaining for Triage of Elderly Women with Atypical Squamous Cells of Undetermined Significance
by: Maria Teresa Bruno, et al.
Published: (2023-05-01)

Progress in immunocytochemical staining for cervical cancer screening
by: Sun H, et al.
Published: (2019-02-01)

Triage Strategies for Non-16/Non-18 HPV-Positive Women in Primary HPV-Based Cervical Cancer Screening: p16/Ki67 Dual Stain vs. Cytology
by: Karolina Mazurec, et al.
Published: (2023-10-01)

Intra-operative cytodiagnosis of primary ovarian choriocarcinoma with Ki67 immunoexpression
by: Asaranti Kar, et al.
Published: (2015-01-01)

Cutaneous Canine Mast Cell Tumor: The Use of Proliferative Markers (Ki-67 and Ki-67 × AgNOR) in Cytological Samples for Diagnosis and Prognosis
by: Christina Marouda, et al.
Published: (2024-01-01)

Role of Dual-Staining p16/Ki-67 in the Management of Patients under 30 Years with ASC-US/L-SIL
by: Cristina Secosan, et al.
Published: (2022-02-01)

Novel concepts in cervical cancer screening: a comparison of VIA, HPV DNA test and p16INK4a/Ki-67 dual stain cytology in Western Kenya
by: Elkanah Omenge Orang’o, et al.
Published: (2020-10-01)

Expression of the Immunohistochemical Markers p16 and Ki-67 and Their Usefulness in the Diagnosis of Cervical Intraepithelial Neoplasms
by: Fernanda Lopes Pontes de Melo, et al.
Published: (2016-02-01)

The Expression of Testin, Ki-67 and p16 in Cervical Cancer Diagnostics
by: Aneta Popiel-Kopaczyk, et al.
Published: (2023-01-01)

Effect of inosine pranobex on p16, Ki-67 expression in patients with HPV-associated cervical intraepithelial neoplasia
by: T V Klinyshkova, et al.
Published: (2018-08-01)

EXPRESSION OF OCT-4, P53, P16 AND KI-67, WITH HPV ASSOCIATED PRECANCER AND CANCER OF THE CERVIX
by: E A Kogan, et al.
Published: (2016-03-01)

Staining Intensity of P16INK4a and Ki-67 Determine the Grade of Cervical Lesion: An Experience from Single Tertiary Care Centre
by: Usha Sarma, et al.
Published: (2023-10-01)

A Comparative Study on the Accuracy and Efficacy Between Dalton and CINtec® PLUS p16/Ki-67 Dual Stain in Triaging HPV-Positive Women
by: Ying Li, et al.
Published: (2022-01-01)

Is Primary HPV with Secondary p16/Ki67 Dual-Stain an Alternative HSIL-Risk Detection Strategy in Cervical Cancer Screening for Women under 30 Years?
by: Martyna Trzeszcz, et al.
Published: (2021-10-01)

Comparison of Ki67 index and P16 expression in different grades of cervical squamous intraepithelial lesions
by: Maryam Sadat Hosseini, et al.
Published: (2023-01-01)

Evaluation of Ki67, p16 and CK17 Markers in Differentiating Cervical Intraepithelial Neoplasia and Benign Lesions
by: Fatemeh Sari Aslani, et al.
Published: (2013-03-01)

The Role of p16/Ki-67 Immunostaining, hTERC Amplification and Fibronectin in Predicting Cervical Cancer Progression: A Systematic Review
by: Septimiu Toader Voidăzan, et al.
Published: (2022-06-01)

EXPRESSION OF P16 MUTANT PROTEIN AND KI67 IN CUTANEOUS AND NON-CUTANEOUS MELANOMA
by: Farhan Akhtar, et al.
Published: (2020-04-01)

Risk of progression of early cervical lesions is associated with integration and persistence of HPV-16 and expression of E6, Ki-67, and telomerase
by: Arianna Vega-Peña, et al.
Published: (2013-01-01)

Hubungan Ekspresi Ki-67 dengan Grading Histopatologi Liposarkoma
by: Afiati, et al.
Published: (2013-09-01)

Expressions of Bcl-2, Bax and Ki67 in the primary pterygium
by: Juan Li, et al.
Published: (2018-05-01)

Immunohistochemical evaluation of BCL-2 and KI-67 proteins in colorectal adenoma.
by: Areege N. Abd, et al.
Published: (2014-07-01)

The utility of p16 INK4a and Ki-67 to identify high-grade squamous intraepithelial lesion in adolescents and young women
by: Diane M Cavalcante, et al.
Published: (2012-01-01)

Neoplasias astrocitárias e correlação com as proteínas p53 mutada e Ki-67 Astrocytic neoplasms and correlation with mutate p53 and Ki-67 proteins
by: Gustavo Rassier Isolan, et al.
Published: (2005-12-01)

Is Ki-67, keratin 16, involucrin, and filaggrin immunostaining sufficient to diagnose inflammatory linear verrucous epidermal nevus? A report of eight cases and a comparison with psoriasis vulgaris
by: Jing Peng, et al.
Published: (2017-10-01)

Combining HPV DNA load with p16/Ki-67 staining to detect cervical precancerous lesions and predict the progression of CIN1–2 lesions
by: Yuejie Li, et al.
Published: (2019-10-01)

Evaluation of the Ki-67 and MCM3 Expression in Cytologic Smear of Oral Squamous Cell Carcinoma
by: Fahimeh Rezazadeh, et al.
Published: (2017-09-01)

Comparative evaluation of the results of an immunocytochemical study of P16/Ki-67 coexpression in patients with cervical intraepithelial neoplasia associated with human papillomavirus
by: Tatiana V. Klinyshkova, et al.
Published: (2021-09-01)

Immunoexpression of Ki-67 and endoglin corroborating hamartomatous nature of sialoangiolipoma
by: Swagatika Panda, et al.
Published: (2017-01-01)

A cytohistological study of Ki-67 expression in ovarian tumors
by: Monisha Choudhury, et al.
Published: (2011-01-01)